Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

High-Flow-Therapy for the Treatment of Cheyne-Stokes-Respiration in Chronic Heart Failure

NCT03102827 is registered in ClinicalTrials.gov with Heart and Diabetes Center North-Rhine Westfalia as lead sponsor.

NCT NCT03102827
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03102827 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
High-Flow-Therapy for the Treatment of Cheyne-Stokes-Respiration in Chronic Heart Failure
Lead sponsor
Heart and Diabetes Center North-Rhine Westfalia
Phase
Phase 3
Overall status
Terminated
Start date
February 2, 2017
Completion date
March 27, 2018
Enrollment
14 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure，congestive